Mark Bustoros, MD, on How to Discuss Preventing or Delaying a Patient’s Treatment

Posted: Thursday, December 19, 2019

Mark Bustoros, MD, of Dana-Farber Cancer Institute, discusses the best way to approach patients with smoldering multiple myeloma about undergoing treatment that may be linked to side effects, but may prevent or delay the onset of active disease.